Risedronate's Role in Reducing Hip Fracture in Postmenopausal Women with Established Osteoporosis.

Clin Med Insights Arthritis Musculoskelet Disord · 2012 · PMC3260522 · PMID 22267947

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

This analysis looked at all fractures; therefore, it is difficult to directly determine a comparative effect on hip fracture, especially considering that ibandronate’s effect on hip fracture in the BONE trial did not reach statistical significance.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.